Oxford Nanopore Technologies plc (OXFYY)

Market Cap	1.78B +3.3%
Revenue (ttm)	280.44M +22.0%
Net Income	-196.31M
EPS	-0.21
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	220
Average Volume	288
Open	7.10
Previous Close	6.80
Day's Range	7.10 - 7.10
52-Week Range	5.96 - 12.45
Beta	0.89
RSI	46.70
Earnings Date	Mar 2, 2026

About OXFYY

Oxford Nanopore Technologies plc engages in the research, development, manufacture, and commercialization of a novel generation of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) sequencing technology that allows the real-time analysis of DNA or RNA. It offers MinION Mk 1D, a portable device for DNA and RNA; GridION and GridION Q, a compact bench top device, which delivers a version of hardware, software, and chemistry. The company also provides PromethION 2 Solo, PromethION 2, PromethION 24, and PromethION 48. Its platform enables its cu...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2005
• Employees: 1,325
• Stock Exchange: OTCMKTS
• Ticker Symbol: OXFYY

Financial Performance

In 2024, OXFYY's revenue was 183.19 million, an increase of 7.97% compared to the previous year's 169.67 million. Losses were -146.19 million, -5.38% less than in 2023.

Financial numbers in GBP